About Aptamer Group
Aptamer Group is a company based in York (United Kingdom) founded in 2008. Aptamer Group has raised $2.2 million across 5 funding rounds from investors including Gov.uk, SPARK Advisory Partners and Turner Pope Investments. Aptamer Group offers products and services including Optimer Platform and Optimer Binders. Aptamer Group operates in a competitive market with competitors including Aptamer Sciences, Base Pair Biotechnologies, Femtogenix, Apta Biotech and Aptus Biotech, among others.
- Headquarter York, United Kingdom
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aptamer Group Plc
-
Annual Revenue
$1.08 M (USD)-50.91as on Jun 30, 2024
-
Net Profit
-$3.71 M (USD)62.25as on Jun 30, 2024
-
EBITDA
-$3.72 M (USD)37.68as on Jun 30, 2024
-
Total Equity Funding
$2.2 M (USD)
in 5 rounds
-
Latest Funding Round
$2.73 M (USD), Post-IPO
Jul 04, 2025
-
Investors
Gov.uk
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Aptamer Group
Aptamer Group is a publicly listed company on the LSE with ticker symbol APTA in UK, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Aptamer Group
Aptamer Group offers a comprehensive portfolio of products and services, including Optimer Platform and Optimer Binders.
Platform for custom aptamer discovery and binding services.
High-affinity binders for therapeutic and diagnostic applications.
People of Aptamer Group
Unlock access to complete
Unlock access to complete
Funding Insights of Aptamer Group
Aptamer Group has successfully raised a total of $2.2M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $2.73 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Aptamer Group
Aptamer Group has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Gov.uk, SPARK Advisory Partners and Turner Pope Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment opportunities in early-stage biotech and pharma are facilitated by Meneldor.
|
Locked | Locked | Locked | |
|
Independent corporate finance advice is provided by SPARK Advisory Partners.
|
Locked | Locked | Locked | |
|
Turner Pope Investments is engaged as a boutique stockbroker providing investment services.
|
Locked | Locked | Locked |
Investor details for Aptamer Group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aptamer Group
Investment portfolio details for Aptamer Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aptamer Group
Detailed financials for Aptamer Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aptamer Group Comparisons
Peer comparison for Aptamer Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aptamer Group
Aptamer Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aptamer Sciences, Base Pair Biotechnologies, Femtogenix, Apta Biotech and Aptus Biotech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Proprietary aptamer technology is utilized for protein analysis.
|
|
| Locked | Locked | Locked |
Services for custom aptamer development
|
|
| Locked | Locked | Locked |
DNA-interactive payload molecules for ADCs are developed by Femtogenix.
|
|
| Locked | Locked | Locked |
Aptamers are developed and provided via SELEX platform technology.
|
|
| Locked | Locked | Locked |
Aptamer-based biotechnological applications are developed for diverse uses.
|
Detailed competitors of Aptamer Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aptamer Group
Complete news archive for Aptamer Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aptamer Group
Aptamer Group was founded in 2008 and raised its 1st funding round 10 years after it was founded.
Aptamer Group is headquartered in York, United Kingdom.
Aptamer Group is a funded company, having raised a total of $2.2M across 5 funding rounds to date.
Annual revenue of Aptamer Group is $1.08M as on Jun 30, 2024.
Aptamer Group was founded in 2008 in York, United Kingdom, and operates within the biotechnology sector. DNA and RNA aptamers are produced using Optimer technology, serving as alternatives to antibodies. These molecules are applied in research reagents, biomarker identification, diagnostic tools, and therapeutic development. Operations focus on nucleic acid-based binders for scientific and medical applications.
Aptamer Group's top competitors include Aptamer Sciences, Base Pair Biotechnologies and Apta Biotech.
Aptamer Group offers Optimer Platform and Optimer Binders.
Yes, Aptamer Group is publicly traded on LSE under the ticker symbol APTA.
Aptamer Group has 4 investors. Key investors include Gov.uk, SPARK Advisory Partners, Turner Pope Investments, and Meneldor.
The ticker symbol of Aptamer Group is APTA on LSE.